BLT 0.00% 2.6¢ benitec biopharma limited

ann out, page-6

  1. 2,027 Posts.
    Quite happy to not see irrational exuberance, it is best if the market simply sees a growing and inexorable Benitec dominance of the ddRNA patent space reflected in a gradually strengthening share price.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.